Logo image of CAMP

CAMP4 THERAPEUTICS CORP (CAMP) Stock Fundamental Analysis

USA - NASDAQ:CAMP - US13463J1016 - Common Stock

3.79 USD
+0.25 (+7.06%)
Last: 10/9/2025, 8:58:15 PM
3.73 USD
-0.06 (-1.58%)
Pre-Market: 10/10/2025, 8:00:02 AM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CAMP. CAMP was compared to 536 industry peers in the Biotechnology industry. The financial health of CAMP is average, but there are quite some concerns on its profitability. While showing a medium growth rate, CAMP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CAMP had negative earnings in the past year.
CAMP had a negative operating cash flow in the past year.
CAMP had negative earnings in each of the past 5 years.
In multiple years CAMP reported negative operating cash flow during the last 5 years.
CAMP Yearly Net Income VS EBIT VS OCF VS FCFCAMP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

CAMP has a Return On Assets of -100.00%. This is in the lower half of the industry: CAMP underperforms 75.37% of its industry peers.
CAMP has a Return On Equity (-127.50%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -100%
ROE -127.5%
ROIC N/A
ROA(3y)-54.3%
ROA(5y)-38.38%
ROE(3y)-82.87%
ROE(5y)-73.07%
ROIC(3y)N/A
ROIC(5y)N/A
CAMP Yearly ROA, ROE, ROICCAMP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CAMP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CAMP Yearly Profit, Operating, Gross MarginsCAMP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10K -10K 20K 30K

More info and screens

4

2. Health

2.1 Basic Checks

CAMP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CAMP has about the same amount of shares outstanding.
CAMP has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CAMP has an improved debt to assets ratio.
CAMP Yearly Shares OutstandingCAMP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CAMP Yearly Total Debt VS Total AssetsCAMP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

CAMP has an Altman-Z score of -4.98. This is a bad value and indicates that CAMP is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CAMP (-4.98) is worse than 61.57% of its industry peers.
CAMP has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
CAMP has a Debt to Equity ratio of 0.00. This is comparable to the rest of the industry: CAMP outperforms 48.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.98
ROIC/WACCN/A
WACC9.55%
CAMP Yearly LT Debt VS Equity VS FCFCAMP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 5.59 indicates that CAMP has no problem at all paying its short term obligations.
CAMP has a Current ratio (5.59) which is in line with its industry peers.
A Quick Ratio of 5.59 indicates that CAMP has no problem at all paying its short term obligations.
CAMP has a Quick ratio of 5.59. This is in the better half of the industry: CAMP outperforms 60.45% of its industry peers.
Industry RankSector Rank
Current Ratio 5.59
Quick Ratio 5.59
CAMP Yearly Current Assets VS Current LiabilitesCAMP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CAMP have decreased strongly by -2147.83% in the last year.
CAMP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -97.99%.
Measured over the past years, CAMP shows a very negative growth in Revenue. The Revenue has been decreasing by -70.90% on average per year.
EPS 1Y (TTM)-2147.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.57%
Revenue 1Y (TTM)-97.99%
Revenue growth 3Y-87.18%
Revenue growth 5Y-70.9%
Sales Q2Q%-97.57%

3.2 Future

Based on estimates for the next years, CAMP will show a very strong growth in Earnings Per Share. The EPS will grow by 21.59% on average per year.
Based on estimates for the next years, CAMP will show a very strong growth in Revenue. The Revenue will grow by 79.12% on average per year.
EPS Next Y67.98%
EPS Next 2Y35.73%
EPS Next 3Y21.59%
EPS Next 5YN/A
Revenue Next Year1925.02%
Revenue Next 2Y106.23%
Revenue Next 3Y79.12%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CAMP Yearly Revenue VS EstimatesCAMP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
CAMP Yearly EPS VS EstimatesCAMP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CAMP. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CAMP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CAMP Price Earnings VS Forward Price EarningsCAMP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAMP Per share dataCAMP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20

4.3 Compensation for Growth

CAMP's earnings are expected to grow with 21.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.73%
EPS Next 3Y21.59%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CAMP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAMP4 THERAPEUTICS CORP

NASDAQ:CAMP (10/9/2025, 8:58:15 PM)

Premarket: 3.73 -0.06 (-1.58%)

3.79

+0.25 (+7.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)N/A N/A
Inst Owners94.08%
Inst Owner Change0%
Ins Owners3.47%
Ins Owner Change0.83%
Market Cap76.41M
Analysts85.45
Price Target9.18 (142.22%)
Short Float %4.48%
Short Ratio0.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.36%
Min EPS beat(2)9.55%
Max EPS beat(2)13.17%
EPS beat(4)2
Avg EPS beat(4)-581.47%
Min EPS beat(4)-2111.25%
Max EPS beat(4)13.17%
EPS beat(8)3
Avg EPS beat(8)-296.37%
EPS beat(12)5
Avg EPS beat(12)-221.4%
EPS beat(16)9
Avg EPS beat(16)-140.29%
Revenue beat(2)2
Avg Revenue beat(2)1704.66%
Min Revenue beat(2)144.61%
Max Revenue beat(2)3264.71%
Revenue beat(4)3
Avg Revenue beat(4)912.54%
Min Revenue beat(4)-100%
Max Revenue beat(4)3264.71%
Revenue beat(8)4
Avg Revenue beat(8)453.58%
Revenue beat(12)5
Avg Revenue beat(12)300.52%
Revenue beat(16)5
Avg Revenue beat(16)222.49%
PT rev (1m)-37.21%
PT rev (3m)-44.62%
EPS NQ rev (1m)30.09%
EPS NQ rev (3m)30.7%
EPS NY rev (1m)20.83%
EPS NY rev (3m)26.79%
Revenue NQ rev (1m)-50%
Revenue NQ rev (3m)4.17%
Revenue NY rev (1m)6.36%
Revenue NY rev (3m)111.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 25.38
P/FCF N/A
P/OCF N/A
P/B 1.91
P/tB 1.91
EV/EBITDA N/A
EPS(TTM)-28.26
EYN/A
EPS(NY)-0.98
Fwd EYN/A
FCF(TTM)-2.31
FCFYN/A
OCF(TTM)-2.28
OCFYN/A
SpS0.15
BVpS1.98
TBVpS1.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -100%
ROE -127.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-54.3%
ROA(5y)-38.38%
ROE(3y)-82.87%
ROE(5y)-73.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 31.95%
Cap/Sales 17.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.59
Quick Ratio 5.59
Altman-Z -4.98
F-Score4
WACC9.55%
ROIC/WACCN/A
Cap/Depr(3y)41.56%
Cap/Depr(5y)49.13%
Cap/Sales(3y)88.82%
Cap/Sales(5y)55.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2147.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.57%
EPS Next Y67.98%
EPS Next 2Y35.73%
EPS Next 3Y21.59%
EPS Next 5YN/A
Revenue 1Y (TTM)-97.99%
Revenue growth 3Y-87.18%
Revenue growth 5Y-70.9%
Sales Q2Q%-97.57%
Revenue Next Year1925.02%
Revenue Next 2Y106.23%
Revenue Next 3Y79.12%
Revenue Next 5YN/A
EBIT growth 1Y-19.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-20.03%
EBIT Next 3Y-18.8%
EBIT Next 5YN/A
FCF growth 1Y10.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.02%
OCF growth 3YN/A
OCF growth 5YN/A